Maximino
Abraldes Lopez-Veiga
Hospital Ramón y Cajal
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (7)
2024
-
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study
Eye (Basingstoke)
-
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration
Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359
2023
-
Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database
British Journal of Ophthalmology, Vol. 108, Núm. 2, pp. 253-262
2020
2018
-
Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration
Acta Ophthalmologica, Vol. 96, Núm. 2, pp. e201-e212
-
Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants
Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72